HLA Typing for Transplant Market : 2018 Prominent Players | Pacific Biosciences of California, Thermo Fischer Scientific, Immucor, Illumina, GenDx and CareDx

HLA Typing for Transplant Marketto exceed USD 720 million by 2024; according to a new research report.
Increasing number of solid organ transplants will fuel industry growth over the forecast timeframe. Growing patient pool suffering from terminal and irreversible organ failure is leading to a surge in solid organ transplant demand. Growing geriatric population will further augment growth as the elderly individuals have a higher susceptibility towards various chronic disorders owing to anatomic and functional changes along with impairment of immune system.

Technological advancements will further aid industry expansion. The industry participants are focusing on developing technologies which substantially improve allele resolution. However, presence of significant gap between number of organs donated and organs required for transplant procedures hinders industry growth. Higher cost of molecular assays used for HLA typing is another barrier hampering adoption rates.

Molecular assays held significant industry share in 2016. Growing demand for molecular tests in HLA typing owing to its ability to provide more accurate results in less time as compared to non-molecular assays will propel segment growth over the forecast timeframe.

Request sample copy of this report @ https://www.gminsights.com/request-sample/detail/1653

Sequencing based molecular assays are poised to witness fastest growth as the technology provides the capability of generating a large amount of clonal sequences in a single sequencing run.
Reagents and consumables segment will grow at a robust rate owing to their requirement in larger quantities and higher frequency of use in HLA typing procedures.

Application of HLA typing for transplant in research held considerable industry share in 2016. Increasing research and development activities focused on developing advanced and rapid methods with higher accuracy will further boost segment growth.

Hospitals segment is poised to witness rapid growth owing to increasing number of patients undergoing organ transplant procedures in these settings.

Make Inquiry about this report @ https://www.gminsights.com/inquiry-before-buying/1653

UK HLA typing for transplant market is poised to witness lucrative growth owing to increasing number of bone marrow donors. Furthermore, adoption of strategies such as ‘taking organ transplantation to 2020’ which aims to increase the authorization rate from 57 percent in 2012/2013 to over 80 percent in 2020 will augment industry expansion.

South Africa HLA typing for transplant market presents a lucrative future opportunity due to the presence of a large patient population base requiring organ transplants. Growing awareness pertaining to the need and importance of organ donation will further fuel demand.

Prominent industry participants include Thermo Fischer Scientific, CareDx, GenDx, Pacific Biosciences, Immucor and Illumina. The industry players adopt various strategies such as partnerships and collaborations, new product launch, distributor agreements and acquisition for strengthening their industry presence. For instance, in April 2016, CareDx acquired Allenex AB. The acquisition has enhanced the company’s position in the HLA typing for transplant industry.

Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.

Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688
Email: sales@gminsights.com

This release was published on openPR.